SIRT2 Antikörper
-
- Target Alle SIRT2 Antikörper anzeigen
- SIRT2 (Sirtuin 2 (SIRT2))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser SIRT2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Spezifität
- Recognizes human sirtuin 2. Detects a band of ~45 kDa by Western blot.
- Kreuzreaktivität
- Human
- Sterilität
- 0.2 μm filtered
- Immunogen
- Recombinant human sirtuin 2.
- Klon
- S2R233-1
- Isotyp
- IgG2b
- Top Product
- Discover our top product SIRT2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives.
- Konservierungsmittel
- Without preservative
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 1 year after receipt when stored at -20°C. - Haltbarkeit
- 12 months
-
- Target
- SIRT2 (Sirtuin 2 (SIRT2))
- Andere Bezeichnung
- Sirtuin 2 (SIRT2 Produkte)
- Hintergrund
- Sirtuin-2 is a NAD-dependent protein deacetylase, which deacetylates the 'Lys-40' of a-tubulin. It is involved in the control of mitotic exit in the cell cycle. Furthermore, a variety of age-associated diseases such as type 2 diabetes, obesity, osteoporosis, and Alzheimer's disease are associated with sirtuins. Selective inhibition of Sirtuin-2 achieves neuroprotection and identifies Sirtuin-2 to be a potential therapeutic avenue in Huntington's and Parkinson's disease.
- UniProt
- Q8IXJ6
-